DSGN Market Cap History Table | ||||||||||||||||||||||||||
Also see: DSGN Shares Outstanding History and DSGN YTD Return |
DSGN Market Cap History Table | ||||||||||||||||||||||||||
Also see: DSGN Shares Outstanding History and DSGN YTD Return |
DSGN Market Cap History Chart | |||||||||||||||||||||||||||
-55.75% CAGR Mouse over chart for data details
|
DSGN Stock Price Chart |
About Design Therapeutics Inc |
Design Therapeutics is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTAC molecules. The U.S. Food and Drug Administration has granted Fast Track designation to Co.'s primary Friedreich ataxia (FA) GeneTAC development candidate (DT-216) for the treatment of patients with FA. Co.'s second GeneTAC development candidate (DT-168) is an eye drop for the treatment of Fuchs Endothelial Corneal Dystrophy. Co.'s third program based on the GeneTAC platform is myotonic dystrophy type-1. Co. continues to develop its GeneTAC portfolio in preclinical studies to address other serious nucleotide repeat expansion-driven monogenic diseases. We show 12 historical shares outstanding datapoints in our DSGN shares outstanding history coverage, used to compute DSGN market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing DSGN market cap history over the course of time is important for investors interested in comparing DSGN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of DSGN versus a peer is one thing; comparing DSGN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like DSGN can fluctuate over the course of history. With this page we aim to empower investors researching DSGN by allowing them to research the DSGN market cap history. |
DSGN Current Stock Quote |
Free DSGN Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
DSGN Share Performance |
Market Cap Peers |
Design Therapeutics (DSGN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
DTIL Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.